Natural History of the Leukodystrophies
Completed
Conditions studied: Leukodystrophies
In brief
The purpose of this study is to: 1. define novel homogeneous groups of patients with LDs and 2. work toward finding the cause of these disorders.
Key facts
- Study ID
- NCT02843555
- Run by
- Baylor Research Institute
- People needed
- 10
- Starts
- 2019-01-23
- Expected to finish
- 2019-01-23
- Last updated by the study team
- 2019-03-22
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Subjects must:
- have clinical and radiographic signs of leukodystrophy without a specific etiology
- no diagnosis of adrenoleukodystrophy, adrenomyeloneuropathy, metachromatic leukodystrophy, Krabbe disease, Canavan disease, a well-defined amino acid organic acid disorder, or a systemic mitochondrial cytopathy.
- First-degree relatives of patients with leukodystrophies of unknown etiology (father, mother, siblings, or sons and daughters of the patients)
- Be able to travel to Baylor University Medical Center in Dallas Texas for evaluation and spend 5-8 working days on site
- Be able to tolerate a general exam and neurological exam
- Be able to tolerate a modest amount of blood drawing, provide a urine specimen, and have a skin biopsy(if not previously done)
- Be able to tolerate the performance of necessary neuroimaging studies to include EEG and Head MRI
- Be able to tolerate a neuropsychological testing and rehabilitation evaluation
- Be able to tolerate spinal tap or nerve biopsy if needed
You may not qualify if…
- Unable to travel to Baylor University Medical Center in Dallas Texas for evaluation
- Refusal to sign a study consent form
- Unable to tolerate the performance of the required testing
Where it is running
- Baylor University Medical Center — Dallas, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.